SCHEMBL17933248

SCHEMBL17933248

CN(c1ccc(-c2ccccc2)cc1)c1ccc(-c2cccc3c2oc2ccccc23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.52
▸ GGPS1 O95749 1/20 0.42
▸ PRKDC P78527 7/20 0.39
▸ PTGES2 Q9H7Z7 1/20 0.39
▸ TNKS O95271 1/20 0.39
▸ CDC14B O60729 2/20 0.38
▸ CDC14A Q9UNH5 2/20 0.38
▸ TOP2A P11388 1/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ CSF1R P07333 1/20 0.35
▸ PDGFRB P09619 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ KIT P10721 1/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ PIK3CD O00329 3/20 0.35
▸ PIK3CB P42338 3/20 0.35
▸ PLA2G2A P14555 1/20 0.35
▸ PLA2G4A P47712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10109557 1.00 ALOX5 (0.52) ALOX5GGPS1PRKDCPTGES2TNKS
SCHEMBL825797 0.96 ALOX5 (0.54) ALOX5GGPS1PRKDCPTGES2TNKS
SCHEMBL27047797 0.96 ALOX5 (0.56) ALOX5GGPS1PRKDCPTGES2TNKS
SCHEMBL27050618 0.91 ALOX5 (0.56) ALOX5GGPS1PRKDCPTGES2TNKS
SCHEMBL19163544 0.91 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2TNKS
SCHEMBL27047804 0.89 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2TNKS
SCHEMBL27047738 0.89 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2TNKS
SCHEMBL25132623 0.88 ALOX5 (0.55) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL10110031 0.88 ALOX5 (0.55) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL10109916 0.88 ALOX5 (0.55) ALOX5GGPS1PRKDCPTGES2CDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240032416-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-25 — — US disclosed
US-9812648-B2 Spirobifluorene compounds for organic electroluminescent devices MERCK PATENT GMBH (DE) 2017-11-07 — — US disclosed
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. 2016-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240032416-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE RER1, LEF1, ELP1 ALOX5 1627/4885GGPS1 2827/4885PRKDC 4862/4885
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF POP1, TERB1, AP2B1 ALOX5 2896/4885GGPS1 1888/4885PRKDC 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback